Promis Neurosciences Inc (PMN.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2012 | 09-2012 | 06-2012 | 03-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 13 | 15 | 16 | 18 | 19 |
| Accounts receivable | 78 | -1 | -19 | -41 | 116 |
| Other Working Capital | 30 | -68 | -131 | 46 | 16 |
| Other Operating Activity | -559 | -581 | -537 | -644 | -761 |
| Operating Cash Flow | $-439 | $-635 | $-671 | $-621 | $-610 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | 0 | -1 | 0 | 0 |
| Purchase Of Investment | 0 | 0 | 0 | -7 | -5 |
| Sale Of Investment | -1 | 3 | 76 | 194 | 382 |
| Investing Cash Flow | $-1 | $3 | $75 | $187 | $377 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | -10 | 31 | 940 | N/A | N/A |
| Other Financing Activity | 0 | 0 | 0 | 659 | 0 |
| Financing Cash Flow | $-10 | $31 | $940 | $659 | $N/A |
| Beginning Cash Position | 572 | 1,146 | 802 | 548 | 750 |
| End Cash Position | 113 | 572 | 1,146 | 817 | 548 |
| Net Cash Flow | $-450 | $-601 | $344 | $225 | $-233 |
| Free Cash Flow | |||||
| Operating Cash Flow | -439 | -635 | -671 | -621 | -610 |
| Capital Expenditure | N/A | 0 | -1 | 0 | 0 |
| Free Cash Flow | -439 | -635 | -672 | -621 | -610 |